S. ÇAY Et Al. , "New Oral Anticoagulants vs Warfarin in Patients with Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants," Venice Arrhythmias 2017 , vol.3, pp.23, 2017
ÇAY, S. Et Al. 2017. New Oral Anticoagulants vs Warfarin in Patients with Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants. Venice Arrhythmias 2017 , 23.
ÇAY, S., ÖZEKE, Ö., ÖZCAN, F., ARAS, D., & TOPALOĞLU, S., (2017). New Oral Anticoagulants vs Warfarin in Patients with Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants . Venice Arrhythmias 2017 (pp.23).
ÇAY, SERKAN Et Al. "New Oral Anticoagulants vs Warfarin in Patients with Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants," Venice Arrhythmias 2017, 2017
ÇAY, SERKAN Et Al. "New Oral Anticoagulants vs Warfarin in Patients with Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants." Venice Arrhythmias 2017 , pp.23, 2017
ÇAY, S. Et Al. (2017) . "New Oral Anticoagulants vs Warfarin in Patients with Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants." Venice Arrhythmias 2017 , p.23.
@conferencepaper{conferencepaper, author={SERKAN ÇAY Et Al. }, title={New Oral Anticoagulants vs Warfarin in Patients with Atrial Fibrillation and Diabetes: A Meta-Analysis of Pioneer Trials of Currently Used New Oral Anticoagulants}, congress name={Venice Arrhythmias 2017}, city={}, country={}, year={2017}, pages={23} }